No Data
Quest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads Conference
Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will...
Quest Diagnostics (DGX) Grows in Digital Pathology With New Deal
Express News | Quest Diagnostics Inc: Pathai Will Continue to Support Its Biopharmaceutical Clients at Its Biopharma Lab
Express News | Quest Diagnostics Inc: Under Terms of Merger, Quest Will Buy Anatomic and Digital Pathology Laboratory Services of Pathai
Express News | Quest Diagnostics Inc: To Acquire Pathai Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis
Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements With PathAI
Transaction is part of wide-ranging collaboration to combine Quest's oncology expertise and scale with PathAI's AI and digital pathology innovations to speed diagnosis, improve quality and reduce cost